Alicia Zhou, PhD, became CRI’s president effective August 26, and succeeded Jill O’Donnell-Tormey, PhD, who had led the Institute since 1993.

The genome is "stirred" by transcription-driven motions of single genes, furthering our understanding of the human genome in ...

An editorial by Fyodor Urnov lays out the urgent case for major reform in the regulatory appraisal of clinical therapies involving CRISPR gene therapies.

Cells change their ribosomes when they receive a danger signal from the immune system, the new study showed. “They change the balance toward a type of ribosome that has a flexible arm sticking out, ...

Antibodies show promise as candidates for therapeutics as well as tools for advancing mechanistic studies of the HER family receptors.

In this GEN webinar, Mark Stockdale will discuss how the application of synthetic biology and artificial intelligence can be ...

Seaport Therapeutics said today it has closed on an oversubscribed $225 million Series B financing, with the proceeds set to ...

Two public companies focused on RNA editing therapies, Korro Bio and ProQR, enjoyed impressive stock surges powered by their best-ever one day gains; their share prices lifted by Wave Life Sciences ...

Researchers suggest research findings might be applicable to other age-related diseases where endothelial dysfunction plays a ...

Data from a new study suggests that in the early phase the damage to the brain starts slowly, before speeding up in the ...

Identifying reliable operational parameters as early as possible in the development process can significantly streamline ...

The awards celebrate the discovery of a new role for CD4 T cells in the cancer immune response and insights into autoimmune ...